SF3B1 and myelodysplastic syndrome: K-562 cells were edited using CRISPR/Cas9 and single-stranded oligodeoxynucleotides (ssODN) to introduce an A > G substitution in codon 700 of the SF3B1 gene, the mutation observed in the majority of MDS patients.